Tularemia natural history, complications and prognosis

Jump to navigation Jump to search

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Tularemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tularemia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Findings

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

Tularemia natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tularemia natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tularemia natural history, complications and prognosis

CDC on Tularemia natural history, complications and prognosis

Tularemia natural history, complications and prognosis in the news

Blogs on Tularemia natural history, complications and prognosis

Directions to Hospitals Treating Tularemia

Risk calculators and risk factors for Tularemia natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The disease has a very rapid onset, with headache, fatigue, dizziness, muscle pains, loss of appetite and nausea. Face and eyes redden and become inflamed. Inflammation spreads to the lymph nodes, which enlarge and may suppurate (mimicking bubonic plague). Lymph node involvement is accompanied by a high fever. Complications may include pneumonia, meningitis, endocarditis, hepatitis, sepsis, or osteomyelitis. The prognosis is usual good for common forms of tularemia. However a high mortality rate is associated with pneumonic and typhoidal variations.[2]

Natural History

  • Infection typically begins with an incubation period of 3 to 6 days.
  • Later clinical manifestations of the disease will display themselves in different ways depending on the type of infection. [1]

General Early Phase

Following an incubation of 3 to 6 days there is a sudden onset of flu-like symptoms including:

Progressive forms of tularemia

Following the early onset, general symptoms, tularemia will often present itself in a specific form. Specific forms of tularemia and their clinical manifestations may be found below:


Ulceroglandular

  • Formation of a skin ulcer near the original site of infection; ulcer may persist for several months.
  • Bacteria may travel throughout the body via the lymphatic system.
  • Lymph nodes may swell resembling a clinical manifestation commonly associated with the bubonic plague.
  • Fatality is less than 3 percent, even when left untreated. [1]

Oculoglandular

Oropharyngeal or Gastrointestinal tularemia

Pneumonic and Typhoidal

  • Pnuemonic disease occurs as a result of an inhalation-based infection.
  • May also be the result of a spread of infection associated with other forms of tularemia.
  • Pneumonic infection may occur without any obvious signs of infection, however typhoidal infection is associated with a fatality rate of 30-60%.

Complications

Due to the inflammation of membranes surrounding central nervous system, liver, and heart, the following complications have been associated with tularemia:

Other complications include:

Prognosis

  • The prognosis is usually good for the common forms of tularemia.
  • Ulceroglandular forms of tularemia usually heal after the course of several months.
  • Even when left untreated ulceroglandular and glandular forms of tularemia are rarely fatal.
  • Fatal forms of tularemia include pnuemonic and thyphoidal variations, with a mortality rate of 30-60%. [1]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Ellis J, Oyston PC, Green M, Titball RW. Tularemia. Clin Microbiol Rev. 2002;15(4):631-46. http://www.ncbi.nlm.nih.gov/pubmed/12364373 Accessed March 8, 2016.

Template:WH Template:WS